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Objectives. This study sought to examine whether passive
smoking is associated with endothelial dysfunction in the coro-
nary arteries.
Background. Long-term exposure to cigarette smoking has been
reported to suppress endothelium-dependent arterial dilation in
humans. Endothelial dysfunction is an early feature of atherogen-
esis, and the impairment of acetylcholine (ACh)-induced coronary
artery dilation indicates coronary endothelial dysfunction.
Methods. We studied 38 women (40 to 60 years old) who had no
known risk factors for coronary artery disease other than tobacco
smoking: 11 nonsmokers who had never smoked and had never
been regularly exposed to environmental tobacco smoke; 19
passive smokers with self-reported histories of exposure to
environmental tobacco smoke of >21 h/day for >210 years; and 8
active smokers. We examined the response of the epicardial
coronary artery diameters (proximal and distal segments of the
left anterior descending [LAD] and left circumflex [LCx]
coronary arteries) to the intracoronary injection of ACh into
the left coronary artery by means of quantitative coronary
angiography.
Results. ACh significantly dilated the distal segment in non-
smokers (percent change from baseline diameter: LAD 13.7 6
3.4%, p < 0.05; LCx 18.8 6 2.9%, p < 0.01) but not the proximal
segment (LAD 7.4 6 3.5%; LCx 3.1 6 5.0%). ACh significantly
constricted all segments of the left coronary artery in passive
smokers (LAD: proximal 220.3 6 3.7%, p < 0.05; distal 222.3 6
4.1%, p < 0.01; LCx: proximal 220.8 6 3.1%, p < 0.05; distal
217.3 6 2.9%, p < 0.01) and active smokers (LAD: proximal
214.8 6 3.4%, p < 0.05; distal 227.2 6 6.0%, p < 0.01; LCx:
proximal 214.5 6 6.6%, p < 0.05; distal 222.4 6 4.0%, p < 0.01).
Thus, ACh constricted most coronary arteries in both passive and
active smokers and dilated the coronary arteries in nonsmokers.
Conclusions. Impairment of ACh-induced coronary artery dila-
tion, indicating coronary endothelial dysfunction, may occur
diffusely in passive smokers as well as in active smokers.
(J Am Coll Cardiol 1998;31:811–5)
©1998 by the American College of Cardiology
Cigarette smoking has been recognized as one of the major risk
factors for cardiovascular disease in both men and women (1).
Furthermore, recent studies have demonstrated that environ-
mental exposure to tobacco smoke (passive smoking), which
includes exposure to both sidestream smoke from burning
cigarettes and exhaled mainstream smoke, has been associated
with an increase in frequency of coronary heart disease (2–7).
Studies in experimental animals have shown that passive
smoking may accelerate atherosclerosis (8) and that it in-
creases platelet aggregation, which induces the likelihood of
thrombus formation (9). The resulting increase in platelet
aggregation and atherosclerosis may contribute to the devel-
opment of ischemic heart disease. Recently, Celermajer et al.
(10) measured the brachial artery diameter in response to
reactive hyperemia in healthy young adults and reported that
passive smoking is associated with endothelial damage. Be-
cause endothelial dysfunction is an early feature of atherogen-
esis (11), it may represent an important marker of early vas-
cular damage. However, few studies have assessed the effect of
passive smoking on coronary endothelial function in humans.
We previously showed (12,13) that intracoronary injection
of acetylcholine (ACh) induces coronary spasm in patients
with coronary spastic angina. The arterial response to ACh is
determined by the balance between the dilator action of
endothelium-derived substances, including nitric oxide, and
direct constrictor action on smooth muscle (14,15). The en-
hanced constrictor response to ACh is at least partly explained
by decreased nitric oxide bioactivity during ACh stimulation
(16,17). Therefore, the impairment of ACh-induced coronary
artery dilation indicates coronary endothelial dysfunction.
We examined whether endothelial function of the coronary
arteries was modulated by prolonged exposure to environmen-
tal tobacco smoke in women who had no known risk factors for
coronary artery disease.
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Methods
Study patients. The study included a consecutive series of
11 lifelong nonsmokers (mean age 55 years, range 42 to 59), 19
passive smokers (mean age 56 years, range 43 to 60) and 8
active smokers (mean age 55 years, range 40 to 60) who were
admitted at Kumamoto Rosai Hospital. All patients underwent
diagnostic cardiac catheterization for evaluation of atypical
chest pain. We examined only women. Because cigarette
smoking is highly prevalent in men compared with women in
Japan, the three groups for gender could not be matched had
we examined both men and women. The passive smokers were
lifelong nonsmokers with a self-reported history of exposure to
environmental tobacco smoke at home or at work, or both, for
$1 h/day for $10 years; the active smokers were current
smokers who had smoked $20 cigarettes/day for .10 years.
Cotinine levels measured in urine (18) on the day of admission
were not detectable (,5.0 ng/ml) in nonsmokers and were
9.1 6 0.5 ng/ml in passive smokers and 1,350 6 60 ng/ml in
active smokers. All patients had no other coronary risk factors,
such as hypercholesterolemia (.240 mg/dl), hypertension
(.140/90 mm Hg or antihypertensive treatment), diabetes
mellitus, low high density lipoprotein (HDL) cholesterol levels
(,35 mg/dl) or a family history of premature coronary artery
disease, except for advancing age. No study subjects had
significant coronary artery stenosis (.25%) or coronary spasm
(associated with chest pain, ischemic electrocardiographic
[ECG] changes and narrowing [.90%] of the epicardial
coronary arteries) provoked by the intracoronary injection of
ACh (12,13). No patient had congestive heart failure, allergy,
active peptic ulcer, chronic obstructive lung disease, history of
gynecologic operation or other clinically serious diseases. All
medications that could have affected coronary vasomotor
reactivity to ACh were withdrawn $7 days before the study.
Written informed consent was obtained from all patients
before the study, which was in agreement with the guidelines
approved by the ethics committee of our institution.
Cigarette smoke is reported (19–21) to contain various
chemicals, such as nicotine, nitric oxide-derived free radicals,
carbon monoxide and large amounts of oxygen free radicals,
that directly or indirectly cause short-term effects on coronary
artery tone and hemodynamic variables. Because we aimed to
determine the intrinsic functional integrity of the coronary
arteries, in the present study, active smokers refrained from
cigarette smoking and passive smokers from environmental
tobacco smoke for $24 h before the study to avoid the possible
effects of the vasoactive substances contained in cigarette
smoke.
Study protocol. Cardiac catheterization and angiographic
study. After the control coronary angiography of the left
coronary artery in the right anterior oblique caudal projection
was performed, a pacing catheter (USCI tripolar electrode
catheter) was inserted into the right ventricular apex for
temporal pacing. The pacing rate was set in the demand mode
at 50 beats/min to prevent bradyarrhythmia during intracoro-
nary injection of ACh. Relations among focal spot, patient and
height of image tube were kept constant during the angio-
graphic study. Recordings from 12 ECG leads were made at
appropriate intervals. Intracoronary injection of ACh was
performed as previously described (12,13). In brief, incremen-
tal doses (50 and 100 mg) of ACh were injected into the left
main coronary artery, and left coronary angiography was
performed 1 min after each injection. The injection time of
each dose of ACh was 20 s, and the time interval between
injections was 5 min. Finally, left coronary arteriograms were
obtained in multiple projections after administration of nitro-
glycerin (NTG) (0.3 mg).
Quantitative coronary angiography. The lumen diameter of
the coronary artery was quantitatively measured using a
computer-assisted coronary angiographic analysis system (Hi-
cor, Siemens, Erlangen, Germany) as previously reported
(14–17). Briefly, automated contour detection was performed
at a digital angiographic work station (Siemens) (22). Mea-
surements were obtained by investigators (H.W., M.D.) who
had no knowledge of the characteristics of the study patients.
The lumen diameters were measured at the proximal,
middle and distal segments of the left anterior descending
(LAD) and left circumflex (LCx) coronary arteries. Angio-
graphic measurements were performed at baseline and after
administration of ACh and nitroglycerin (NTG). A Judkins
catheter was used to calibrate the arterial diameter in millime-
ters. Special care was taken to perform all measurements at the
same sites by use of anatomic references.
The response of the coronary artery diameter to the ACh
and NTG was expressed as the percent change from baseline
coronary diameter.
Statistical analysis. Results are shown as mean value 6
SE. The percent diameter changes in all coronary segments,
age, total serum cholesterol levels, blood pressure and other
variables were statistically compared among the groups with
one-way analysis of variance followed by the Scheffe´ test.
Variables and frequencies between two groups were statisti-
cally compared by an unpaired t test and by chi-square analysis,
respectively. A p value ,0.05 was considered statistically
significant.
Results
Baseline characteristics. There was no significant differ-
ence in age, blood pressure, total cholesterol level and low
density lipoprotein and HDL cholesterol levels among the
three groups (Table 1). There was no significant difference in
Abbreviations and Acronyms
ACh 5 acetylcholine
ECG 5 electrocardiogram, electrocardiographic
HDL 5 high density lipoprotein
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
NTG 5 nitroglycerin
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frequencies of postmenopausal state among the three groups
(i.e., 9 [82%] of 11 nonsmokers, 6 [75%] of 8 active smokers, 15
[79%] of 19 passive smokers). No study patient had any
hormone replacement therapy. There was no significant differ-
ence in the self-reported hours of aerobic exercise (e.g., sports,
walking, cycling, jogging) among the three groups (4.1 6
0.3 h/week in nonsmokers, 3.9 6 0.2 h/week in passive smokers,
3.7 6 0.4 h/week in active smokers, p 5 NS among the three
groups).
In the 19 passive smokers, exposure to environmental
tobacco smoke was light in 10 patients (3.7 6 1.4 h/day) and
heavy in the remaining 9 patients (7.8 6 2.6 h/day). The 10
light passive smokers had been exposed to environmental
tobacco smoke at home; 5 of the 9 heavy passive smokers had
been exposed at work; and the remaining 4 of the heavy
smokers both at home and at work. There was no significant
difference in age, blood pressure and serum cholesterol levels
between light and heavy passive smokers.
Comparison of response to ACh. Figure 1 shows the diam-
eter changes at the proximal, middle and distal segments of the
left coronary artery in response to 100 mg of ACh in the non-
smokers, passive smokers and active smokers. In the nonsmok-
ers, ACh significantly dilated the distal segment of the LAD
(percent change from the baseline: 13.7 6 3.4%, p , 0.05 vs.
baseline diameter), but it did not significantly change the
proximal and middle segments as a whole (7.4 6 3.5% and
4.6 6 3.4%, respectively). ACh significantly dilated the middle
and distal segments of the LCx (9.7 6 3.4%, p , 0.05 and
18.8 6 2.9%, p , 0.01, respectively, vs. baseline diameter) but
did not significantly change the proximal segments (3.1 6
5.0%) (Fig. 1). In the passive smokers, ACh significantly
constricted all segments of the left coronary artery (% change
from baseline: LAD proximal 220.3 6 3.7%, p , 0.05; LAD
middle 223.1 6 3.3%, p , 0.01; LAD distal 222.3 6 4.1%,
p , 0.01; LCx proximal 220.8 6 3.1%, p , 0.05; LCx middle
219.1 6 13.1%, p , 0.01; LCx distal 217.3 6 2.9%, p , 0.01)
(Fig. 1). In the active smokers, ACh significantly constricted all
segments of both the LAD and LCx (percent change from the
baseline: LAD proximal 214.8 6 3.4%, p , 0.05; LAD middle
226.3 6 4.6%, p , 0.01; LAD distal 227.2 6 6.0%, p , 0.01;
LCx proximal 214.5 6 6.6%, p , 0.05; LCx middle 221.8 6
5.4%, p , 0.01; LCx distal 222.4 6 4.0%, p , 0.01).
Figure 1 also shows a significantly greater constriction of
the coronary arteries in response to ACh injection at all
segments in both the passive and active smokers than those in
the nonsmokers. The degree of ACh-induced coronary con-
striction was similar in both the passive and the active smokers.
The degree of constriction of the coronary arteries of heavy
passive smokers was comparable to that in light passive
smokers (Fig. 2).
Comparison of response to NTG. NTG increased the cor-
onary artery diameter of all segments in the active, passive and
nonsmokers. The percent increase in coronary diameter after
NTG injection was comparable among the three groups (Fig.
3).
Discussion
Active smoking has long been established as one of the
major coronary risk factors (1). Furthermore, exposure to
environmental tobacco smoke, so-called passive smoking, may
also have deleterious cardiovascular effects (2–9). The present
study demonstrated that passive smoking is strongly associated
Figure 1. Percent change (mean 6 SE) in lumen diameters from
baseline values in proximal, middle and distal segments of the LAD
(left) and LCx (right) in response to intracoronary injection of ACh
(100 mg) in nonsmokers, passive smokers and active smokers. *p ,
0.05, †p , 0.01.
Figure 2. Percent change (mean 6 SE) in lumen diameters from
baseline values in proximal, middle and distal segments of the LAD
and LCx in response to intracoronary injection of ACh (100 mg) in
light and heavy passive smokers. There was no significant difference
between the two groups.











Age (yr) 53 6 2 56 6 2 55 6 2
SBP (mm Hg) 120 6 5 115 6 3 124 6 3
DBP (mm Hg) 75 6 4 71 6 2 74 6 2
Total-C (mg/dl) 182 6 5 187 6 5 184 6 4
HDL-C (mg/dl) 52 6 4 54 6 4 52 6 2
LDL-C (mg/dl) 116 6 4 113 6 4 109 6 7
*p 5 NS for all comparisons. Data presented are a mean value 6 SE. DBP 5
diastolic blood pressure; HDL-C 5 high density lipoprotein cholesterol; LDL-
C 5 low density lipoprotein cholesterol; SBP 5 systolic blood pressure;
Total-C 5 total cholesterol.
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with impairment of endothelium-dependent coronary artery
dilation.
Passive smoking and coronary endothelial vasomotor func-
tion. The endothelium is an important modulator of coronary
vasodilation, mainly through the release of endothelium-
derived nitric oxide, and the arterial response to ACh depends
on the integrity of this tissue (23). Endothelium-dependent
vasodilation in response to ACh is impaired during the ath-
erosclerotic process (14,15,24,25), and smoking and other
coronary risk factors have been shown (16,26) to be associated
with impairment of ACh-induced endothelium-dependent ar-
terial dilation in asymptomatic adults. The present study shows
that ACh constricted all coronary artery segments in both the
active and passive smokers but dilated most of coronary artery
segments in the nonsmokers. However, the degree of NTG-
induced coronary dilation was comparable among the three
groups. Thus, on the basis of our previous study (16), the
enhanced constrictor response to ACh may be at least partly
explained by the decrease in endothelial nitric oxide bioactivity
during ACh stimulation. Therefore, not only active smoking
but also passive smoking seems to be one of the important risk
factors of endothelium dysfunction in the coronary arteries, an
early feature of atherosclerosis. It is also possible that the
supersensitivity of smooth muscle to the constrictor effect of
ACh may also partly contribute to the enhanced constrictor
response to ACh.
There was no significant difference in the diameter changes
of all segments between heavy and light passive smokers. This
result suggests that some of the effects of cigarette smoke on
coronary artery vasomotor reactivity may reach a saturation
point when exposure to environmental tobacco smoke is
$1 h/day for $10 years, so that a monotonic dose–response
effect may not exist. However, it is possible that the lack of the
dose–response effect may be due to the small number of
patients studied. Furthermore, the intensity of exposure to
environmental tobacco smoke depends on a large number of
variables, such as the number of hours of exposure per day, the
proximity to active smokers in the home or at work and the size
and ventilation of the rooms in which passive smoking occurs.
The intensity of the passive smoking is also difficult to quantify
exactly by the self-reporting system of the passive smoking.
Further studies will be necessary to resolve this issue because
whether there is a dose–response relation between exposure to
environmental tobacco smoke and death due to the environ-
mental tobacco smoke (6,27) is still controversial.
Possible mechanisms of endothelial dysfunction in passive
smokers. In the present study, the degree of ACh-induced
coronary constriction was similar in the passive and active
smokers. Although this may indicate equivalent exposure to
smoking-related products between the two groups, it allows
comparison of the susceptibility of the coronary artery wall to
damage from active smoking with that from passive smoking.
Environmental tobacco smoke consists of sidestream smoke
(from the burning ends of cigarettes), exhaled mainstream
smoke and a vaporphase of components that diffuse through
cigarette paper into the environment. Approximately 85% of
passive smoke exposure is from sidestream smoke, and 15% of
that is from mainstream smoke (5). Because cigarettes burn at
high temperatures during inhalation, combustion is complete,
and some toxic components of tobacco smoke are broken
down or filtered out before inhalation. For example, the
concentration of carbon monoxide is 2.5 times higher in
sidestream smoke than in mainstream smoke (4). More than
4,000 chemicals have been found, and .50 substances have
been identified as carcinogens in environmental tobacco
smoke (28). The particles in sidestream smoke have a smaller
diameter than those in mainstream smoke and are more likely
to be deposited in the most distant alveolar portions of the
lung (29). Exposure to environmental tobacco smoke may
cause endothelial dysfunction in part from the injurious effect
of these small compounds or from secondary chemical reac-
tions on the vascular endothelium, or both.
Large-scale epidemiologic studies (2–7) have consistently
linked passive smoking to an excess risk of atherosclerotic
heart disease. The present study showed that not only active
smokers but also passive smokers have significantly impaired
coronary endothelial function, an early process of atheroscle-
rosis. Therefore, passive smoking may be a relevant risk factor
for heart disease morbidity and mortality.
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